Online editions of The Times and Guardian have a review of neurobiologist Steven Rose’s new book The 21st Century Brain, that discusses the motivations behind the funding and support for neuroscience research.
Rose is a controversial critic of many aspects of mainstream science, and his new book argues that the recent explosion in psychology and neuroscience has been driven by funders only wanting directly marketable results, rather than knowledge about the brain for the good of all. This, he argues, goes hand-in-hand with profit-driven drug development, neuromarketing and other explicity commercial projects.
What Rose seems particularly concerned about, is not commercial projects per se, but the effect that such funding is having on neuroscience itself. For example, the promotion of purely biological theories of mental illness by drug companies has worried many scientists who want a more wide-ranging approach.